Abstract
Radiation recall dermatitis (RRD) refers to an acute inflammatory skin reaction appearing on a previously irradiated area following the systemic administration of a reaction-triggering agent. Despite various hypotheses, the pathomechanism of RRD appears complex and is still not fully understood. In addition, no clinical guidelines exist concerning whether drug treatment should be continued upon manifestation of an associated radiation recall phenomenon. We present the case of a patient with docetaxel-induced RRD, which was successfully treated with topical steroids and systemic antihistamines; re-challenge to docetaxel did result in very mild remanifestation of skin reactions.
Zusammenfassung
Die Strahlen-Recall-Dermatitis (RRD) ist eine akute entzündliche Reaktion der Haut in einem zuvor bestrahlten Areal als Reaktion auf die systemische Applikation eines triggernden Agens. Der zugrunde liegende Pathomechanismus ist bisher nicht vollständig geklärt. Ferner gibt es keine klinischen Leitlinien dazu, ob bei einem assoziierten RRD-Phänomen die medikamentöse Behandlung fortgesetzt werden sollte oder nicht. Vorgestellt wird ein Fall von Docetaxel-induzierter RRD, welche erfolgreich mit topischen Steroiden und systemischen Antihistaminika behandelt wurde. Eine erneute Docetaxel-Exposition des Patienten ging mit einer sehr milden Remanifestation der kutanen Effloreszenzen einher.
References
Burris HA, Hurtig J (2010) Radiation recall with anticancer agents. Oncologist 15(11):1227–1237
D’Angio GJ, Farber S, Maddock CL (1959) Potentiation of x‑ray effects by actinomycin D. Radiology 73:175–177
Camidge R, Price A (2001) Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 59(3):237–245
Caloglu M, Yurut-Caloglu V, Cosar-Alas R (2007) An ambiguous phenomenon of radiation and drugs: recall reactions. Oncol Res Treat 30(4):209–214
National Cancer Institute (2009) Common Terminology Criteria for Adverse Events, Version 4.0. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Last access: 13 March 2016
Abadir R, Liebmann J (1995) Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol 7(5):325–326
Boström A, Sjölin-Forsberg G, Wilking N (1999) Radiation recall – another call with tamoxifen. Acta Oncol 38(7):955–959
Acevedo F, Arriagada P, Ibañez C (2013) Radiation recall dermatitis: report of two cases. Int Canc Conf J 2(4):229–233
Putnik K, Stadler P, Schäfer C, Koelbl O (2006) Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy – case report and review of literature. Radiat Oncol 1:32
Rhee J, Kim GE, Lee CH (2014) Radiation recall dermatitis induced by tamoxifen during adjuvant breast cancer treatment. Radiat Oncol J 32(4):262–265
Conen K, Mosna-Firlejczyk K, Rochlitz C (2015) Vemurafenib-induced radiation recall dermatitis: case report and review of the literature. Dermatology 230(1):1–4
Burdon J, Bell R, Sullivan J, Henderson M (1978) Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA 239(10):931
Kodym E, Kalinska R, Ehringfeld C (2005) Frequency of radiation recall dermatitis in adult cancer patients. Onkologie 28(1):18–21
Pardo J, Mena A, Prieto I (2013) Radiation Recall Dermatitis Development: An Observational Study in 350 Breast Cancer Patients. Int J Radiat Oncol Biol Phys 87(2):214
Smith KJ, Germain M, Skelton H (2002) Histopathologic features seen with radiation recall or enhancement eruptions. J Cutan Med Surg 6(6):535–540
Giesel BU, Kutz GG, Thiel HJ (2001) Recall-Dermatitis durch Docetaxel-Reexposition nach Gehirnbestrahlung. Fallbeobachtung und Literaturübersicht. Strahlenther Onkol 177(9):487–493
Kandemir EG, Karabudak O, Maydagli A (2005) Docetaxel-induced radiation recall dermatitis. Swiss Med Wkly 135(1–2):34–35
Morkas M, Fleming D, Hahl M (2002) Challenges in oncology. Case 2. Radiation recall associated with docetaxel. J Clin Oncol 20(3):867–869
Piroth MD, Krempien R, Wannenmacher M, Zierhut D (2002) Radiation recall dermatitis from docetaxel. Onkologie 25(5):438–440
Duncker-Rohr V, Freund U, Momm F (2014) Radiation recall dermatitis after docetaxel chemotherapy. Treatment by antioxidant ointment. Strahlenther Onkol 190(5):491–493
Samur M, Garipagaoglu M, Akbulut H (2001) Radiation recall effect with docetaxel: Is it a barrier for sandwich approach of radiotherapy sequencing in adjuvant breast cancer treatment? Turkish J Cancer 31(2):82-86
Culp LR, Pou AM, Jones DV (2004) A case of radiation recall mucositis associated with docetaxel. Head Neck 26(2):197–200
Camidge DR, Kunkler IH (2000) Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence. Clin Oncol 12(4):272–273
Yeo W, Leung SF, Johnson PJ (1997) Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold. Eur J Cancer 33(4):698–699
Chen SS, Strauss JB, Shah AP (2009) Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy 8(3):331–334
Borgia F, Guarneri C, Guarneri F (2005) Radiation recall dermatitis after docetaxel administration: absolute indication to replace the drug? Br J Dermatol 153(3):674–675
Mizumoto M, Harada H, Asakura H (2006) Frequency and characteristics of docetaxel-induced radiation recall phenomenon. Int J Radiat Oncol Biol Phys 66(4):1187–1191
Stelzer KJ, Griffin TW, Koh WJ (1993) Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 71(4):1322–1325
Mayer EG, Poulter CA, Aristizabal SA (1976) Complications of irradiation related to apparent drug potentiation by adriamycin. Int J Radiat Oncol Biol Phys 1(11–12):1179–1188
Hellman S, Botnick LE (1977) Stem cell depletion: an explanation of the late effects of cytotoxins. Int J Radiat Oncol Biol Phys 2(1–2):181–184
Wright EG (1998) Radiation-induced genomic instability in haemopoietic cells. Int J Radiat Biol 74(6):681–687
Lorimore SA, Wright EG (2003) Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol 79(1):15–25
Acknowledgements
The authors would like to thank Sokratis Papaioannou MSc for his help in the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
I. Strouthos, N. Tselis, and N. Zamboglou state that there are no conflicts of interest.
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (in its most recently amended version). Informed consent was obtained from the patient included in this case study.
The authors state the accompanying manuscript is in compliance with ethical guidelines.
Rights and permissions
About this article
Cite this article
Strouthos, I., Tselis, N. & Zamboglou, N. Docetaxel-induced radiation recall dermatitis. Strahlenther Onkol 192, 730–736 (2016). https://doi.org/10.1007/s00066-016-0984-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-016-0984-x
Keywords
- Antihistaminics
- Irradiation
- Anti-inflammatory agents, non-steroidal
- Corticosteriods
- Radiation, sensitizing agents